Can MDMA treat the
effects of Post Traumatic Stress Disorder?
By Zoe Shwidock
3,4-methylenedioxymethamphetamine,
also known as MDMA or ecstasy, has been recently getting much publicity with
being associated as a “party drug” that teenagers and young adults have been
illegally ingesting. MDMA has become quite the hit in dance clubs and concerts
internationally, due to the euphoric feeling one gets after taking it.
Kupferschmidt (2014) says that ingesting MDMA activates brain receptors for
dopamine and noradrenaline and releases serotonin from nerve endings, which
causes this feeling of elation. Now though that sounds like a great time, I’m
not encouraging my readers to go out and start “rolling” on MDMA so fast. The
U.S. Drug Enforcement Agency (DEA) has ranked MDMA among the most dangerous
drugs after many have died from dehydration and there have been some reports of
brain damage (Kupferschmidt, 2014).
Psychotherapists
began giving MDMA to their patients who were diagnosed with PTSD in order to
eliminate an element of fear in discussing their experiences and foster a
trusting atmosphere. Kupferschmidt (2014) uses Rick Doblin’s experience as an
example. Doblin first tried MDMA when he was 29 and described his experience as
one that “helped open me up to my emotions and enabled me to feel deep and
profound love.” Since then, he has dedicated his career to fighting for the use
of MDMA as a therapeutic drug.
He
founded The Multidisciplinary Association for Psychedelic Studies (MAPS) where
he has been conducting studies to prove the connection between MDMA as a
treatment for PTSD. In his study, Doblin enrolled 20 patients who were
experiencing PTSD, most were female sexual assault victims. After 2 months, 10
out of the 12 patients who had received MDMA along with psychotherapy no longer
met the criteria for PTSD, compared with only two out of eight patients who had
received a placebo (Kupferschmidt, 20140). MAPS is in funding for a second
study to be performed in Israel, Canada and the U.S. Psychiatrist David Nutt of
Imperial College London has been quoted saying the potential that MDMA has to
help PTSD patients is clear (Kupferschmidt, 2014). Doblin is hopeful that his
studies will prove this clear connection and that MDMA will become a
prescription medicine by 2021.
I
would just like to clarify that I’m not recommending this as a treatment for my
readers if you are diagnosed with PTSD. This is still an ongoing study with no
definitive answer on its effectiveness. I was just surprised that this study
was even being done and therefore decided to share it with you. If you have,
however, taken MDMA as an attempt for treatment, I’d love to hear about your
personal experience! Feel free to comment or email me!
Kupferschmidt, Kai. (July 2014). Can ecstasy treat the agony
of PTSD? Science Magazine, vol. 345 (no.
6192), pp. 22-23. Retrieved from http://www.sciencemag.org.ezaccess.libraries.psu.edu/content/345/6192/22.long
No comments:
Post a Comment